Abstract
A study was conducted in twelve glaucomatous dogs to assess the efficacy of the combination of dorzolamide and timolol in the treatment of glaucoma in dogs. The study included twelve dogs with glaucoma of any age, breed, or gender. On the day of presentation, the 14th, 28th and 42nd days, the intraocular pressure (IOP) was monitored with an applanation tonometer. For 42 days, all dogs received topical instillation of a combination of dorzolamide (2%) and timolol (0.5%) eye drops, one drop twice daily. In all the dogs, there was a shift in IOP towards the established normal level within two weeks of therapy. The study revealed that topical use of a combination of dorzolamide and timolol eye drops twice daily was successful in lowering IOP in dogs with glaucoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
